Cardiothoracic & vascular anesthesia

Optimizing Risk Prediction: Comparative Study of Surgical Outcome Risk Tool Versions 1 and 2 in Aortic Surgery

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

In thoracic aortic surgery, SORT V2 provides a pragmatic option for preoperative risk estimation, with good discrimination and reliable calibration across the full cohort and key subgroups.

Study context

Population
Adults undergoing elective or emergency thoracic aortic surgery, single tertiary academic centre, 2014–2025
Participants
829 adults
Exposure
Surgical Outcome Risk Tool (SORT) V1 vs SORT V2 vs EuroSCORE II
Outcome
Operative mortality prediction (discrimination by AUC; calibration by Hosmer-Lemeshow test, observed-to-expected ratios, model deviance, Cox-Snell R²)
Methodological detailssingle-centre, bootstrap internal validation
  • Single-centre
  • Bootstrap internal validation

Main finding

As reported in the abstract

Prediction of operative mortality, total cohort
GroupAUC
SORT V20.82

SORT V2

AUC0.82
Overall operative mortality 38/829
4.6%

Observational data: associations, not effects.

Further findings

OutcomeValues
Prediction of operative mortality, dissection cases (subgroup)German Registry for Acute Type Aortic Dissection AUC 0.79

Prediction of operative mortality, dissection cases (subgroup)

German Registry for Acute Type Aortic Dissection highest discrimination; Penn classification most favorable calibration; SORT V2 acceptable calibration, comparing favorably with EuroSCORE II

Prespecified subgroups and bootstrap internal validation

Performance preserved in prespecified subgroups; bootstrap internal validation supported stability of estimates

Original publication

Optimizing Risk Prediction: Comparative Study of Surgical Outcome Risk Tool Versions 1 and 2 in Aortic Surgery. J Cardiothorac Vasc Anesth. Published 26 October 2025. doi:10.1053/j.jvca.2025.10.034

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.